NASDAQ$BTSG

Brightspring Health Services Inc · Q1 2026 earnings

Q1 2026 earnings ·

Briefing

BTSG reported Q1 2026 revenue of $3.6B and net income of $148.8M, with diluted EPS of $0.67.

For Q1 2026, BTSG reported revenue of $3.6B and net income of $148.8M in the quarterly 10-Q. Management discusses segment performance, costs, and liquidity in MD&A.

  • Revenue of $3.6B for Q1 2026.
  • Net income of $148.8M; diluted EPS $0.67.
  • Operating income $121.4M.
  • Operating trends and segment mix are detailed in the quarterly report.
  • Liquidity, capital allocation, and macro exposure are discussed in MD&A.

Headline financials

Total Revenue

$3.61B

Previous: $2.88B+25.6%
EPS (adj)

$0.67

Previous: $0.35+91.4%
Capital Expenditures

-$21.5M

Previous: -$17.6M-22.2%
Free Cash Flow

$101M

Previous: $11.9M+751.4%
Net Income

$149M

Previous: $29.5M+403.6%
Operating Income

$121M

Previous: $50.7M+139.4%
Gross Profit

$482M

Previous: $338M+42.5%
Cash & Equivalents

$889M

Previous: $52.3M+1598.2%
Total Assets

$6.21B

Previous: $5.85B+6.3%

Revenue & EPS history

Brightspring Health Services Inc · Revenue · Quarterly

$3.61B

Q1 2026+25.6%vs Q1 2025
Beat estimate in 2 of 2 quarters(100%)
ActualEstimate

Forward guidance

The 10-Q does not provide numeric consolidated annual EPS guidance for BTSG. Management commentary in MD&A covers costs, capital, and sector-specific risks.

Tailwinds

  • Management discusses operational priorities and liquidity in the quarterly filing.
  • Segment or product trends are disclosed where applicable to the business model.

Headwinds

  • Macro, input-cost, and interest-rate exposure can affect near-term results.
  • One-time items, impairments, or fair-value marks may distort quarterly comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

+4.4%

Avg return

Earnings day

+7.8%

Avg return

5 days after

+15.8%

Avg return

30 days after

75%

6 / 8 earnings

Positive

+16.6%

Q1 2025

Best reaction

-8.7%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.6%+9.9%+28.5%
Q4 2025+3.2%+4.6%+5.5%
Q3 2025+0.5%-2.3%+7.8%
Q2 2025-4.9%-0.7%+14.7%
Q1 2025+16.6%+28.7%+33.0%
Q3 2024+15.2%+22.6%+28.9%
Q2 2024-8.7%-8.1%+2.6%
Q1 2024+3.8%+7.7%+5.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro